1. Home
  2. TARS vs IAC Comparison

TARS vs IAC Comparison

Compare TARS & IAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • IAC
  • Stock Information
  • Founded
  • TARS 2016
  • IAC N/A
  • Country
  • TARS United States
  • IAC United States
  • Employees
  • TARS N/A
  • IAC N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • IAC Computer Software: Programming Data Processing
  • Sector
  • TARS Health Care
  • IAC Technology
  • Exchange
  • TARS Nasdaq
  • IAC Nasdaq
  • Market Cap
  • TARS 2.8B
  • IAC 2.7B
  • IPO Year
  • TARS 2020
  • IAC 1992
  • Fundamental
  • Price
  • TARS $77.39
  • IAC $32.05
  • Analyst Decision
  • TARS Strong Buy
  • IAC Buy
  • Analyst Count
  • TARS 7
  • IAC 12
  • Target Price
  • TARS $69.86
  • IAC $48.67
  • AVG Volume (30 Days)
  • TARS 461.9K
  • IAC 1.4M
  • Earning Date
  • TARS 11-04-2025
  • IAC 11-03-2025
  • Dividend Yield
  • TARS N/A
  • IAC N/A
  • EPS Growth
  • TARS N/A
  • IAC N/A
  • EPS
  • TARS N/A
  • IAC N/A
  • Revenue
  • TARS $366,100,000.00
  • IAC $3,653,760,000.00
  • Revenue This Year
  • TARS $139.46
  • IAC N/A
  • Revenue Next Year
  • TARS $49.91
  • IAC $0.08
  • P/E Ratio
  • TARS N/A
  • IAC N/A
  • Revenue Growth
  • TARS 182.44
  • IAC 23.49
  • 52 Week Low
  • TARS $38.51
  • IAC $29.56
  • 52 Week High
  • TARS $78.76
  • IAC $50.49
  • Technical
  • Relative Strength Index (RSI)
  • TARS 66.65
  • IAC 39.59
  • Support Level
  • TARS $70.84
  • IAC $33.71
  • Resistance Level
  • TARS $78.76
  • IAC $34.43
  • Average True Range (ATR)
  • TARS 3.29
  • IAC 1.04
  • MACD
  • TARS 0.35
  • IAC -0.02
  • Stochastic Oscillator
  • TARS 88.54
  • IAC 50.20

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About IAC IAC Inc.

IAC Inc is comprised of businesses including Angi Inc, Dotdash Meredith and Care.com, among many others ranging from early stage to established businesses. Its Dotdash Meredith segment consists of its Digital and Print businesses. Angi segment offers repairing and remodeling homes to cleaning and landscaping services. Care.com segment is a online destination for families to connect with caregivers for their children, aging parents, pets and homes and for caregivers to connect with families seeking care services. Search segment consists of a collection of websites providing general search services and information, and a Desktop business, which includes business-to-business partnership operations.

Share on Social Networks: